Vir Biotechnology, Inc. VIR Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s goodwill?
- Vir Biotechnology, Inc. (VIR) reported goodwill of $16.94M in Q1 2026.
- How has Vir Biotechnology, Inc.'s goodwill changed year-over-year?
- Vir Biotechnology, Inc.'s goodwill decreased by 0.0% year-over-year, from $16.94M to $16.94M.
- What is the long-term trend for Vir Biotechnology, Inc.'s goodwill?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s goodwill has grown at a 0.0% compound annual growth rate (CAGR), from $16.94M to $16.94M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.